Market Access (oder alternativ „Kostenerstattung“) im Gesundheitswesen ist DIE Schlüsselkompetenz, um mit einem neuen Medikament, einem Medizinprodukt oder einer digitalen Gesundheitsanwendung kommerziell erfolgreich zu sein. Da der Marktzugang jedoch ein komplexer Bereich ist, der verschiedene Disziplinen umfasst und sich ständig verändert, kann es schwierig sein, mit den verschiedenen Entwicklungen in diesem Bereich in der Welt Schritt zu halten.

MAP ist DER zweiwöchentliche Marktet Access Podcast von MArS Market Access & Pricing Strategy, Ihrem Beratungsunternehmen für das Gesundheitswesen in den deutschsprachigen Märkten, welches Sie über Market Access, Erstattung und Preisgestaltung in den D-A-CH-Ländern und weltweit auf dem Laufenden hält. Mit MAP erhalten Sie einen Überblick über die wichtigsten Market Access Steme und -Prozesse sowie über die neuesten Änderungen in der Gesetzgebung, einschließlich Stellungnahmen und Meinungen der wichtigsten Entscheidungsträger und Interessenvertreter aus verschiedenen Ländern.

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement including the famous article 71, which allows an early paid access.

Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate.

In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

Are you intrigued by the pulsing heart of Spain’s healthcare sector, or are you considering navigating the vibrant market of medical devices in Spain? Dive into our latest Market Access podcast episode where we unravel the complexities and dynamism of Spain’s medical landscape. 🇪🇸

Join us as Sergio Gill, a seasoned veteran with over three decades in the medical device industry, shares his invaluable insights. From understanding Spain's unique regional healthcare powers to decoding the reimbursement conundrums, Sergio illuminates the path to successful market entry and what makes Spain not just culturally, but commercially captivating.

Here’s a sneak peek at what you’ll discover:

🔹 The striking differences between the pharmaceutical and medical device sectors in Spain.

🔹 An insider’s guide to Spain’s decentralized healthcare approach and how it impacts market access.

🔹 Key strategies for companies aiming to penetrate the Spanish market – straight from the expert.

🔹 The burgeoning world of digital health in Spain and the emerging trends to watch out for.

Whether you're a startup eyeing Spain for your next big launch or a seasoned player looking to deepen your market footprint, this episode is packed with strategic gold.

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: map-market-access.captivate.fm

MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: marketaccess-pricingstrategy.de

#MedicalDevices #Healthcare #MarketAccess #Spain #Podcast #DigitalHealth #Innovation #BusinessStrategy

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

We are looking at Israel a lot recently, but did you know how innovative this rather small country is in terms of healthcare?

Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the same time, Israel has a higher life expectancy and lower infant mortality. So, better results for less money?! How does Israel do this?

Dr. Stefan Walzer and Mirel Stelian are discussing in depth, how the application and reimbursement process works and what options are available for companies who want to enter the Israeli market. If you want to understand the Israeli health care market and specifically the reimbursement process in Israel, you should not miss this episode. 

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

 

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #europe #israel